Rachel has been a regulatory affairs specialist for twelve years. She has seen inspections from both sides, having worked at investigator sites before joining a contract research organization. She understands that warning letters represent the most serious inspection outcomes, the cases where FDA determined that the violations were significant enough to warrant formal agency action.

But as she begins reading, she notices something that confirms what she has long suspected. The same deficiencies appear again and again. Missing consent forms. Incomplete delegation logs. Gaps in investigational product accountability. Version control failures. Monitoring reports that were never finalized. The specific sites and sponsors differ, but the patterns are remarkably consistent.

"These are not novel problems," she tells her colleague Marcus Okonkwo during their afternoon meeting. "These are the same problems, happening at different sites, for the same underlying reasons. If we can understand the root causes, we can prevent them."

This lesson is about those patterns. We will examine the most common TMF deficiencies cited in regulatory findings, understand why they occur, and recognize how small documentation gaps can compound into major inspection findings. My goal is not to frighten you with cautionary tales. It is to equip you with the knowledge to recognize vulnerabilities in your own documentation systems before an inspector does.

Rachel has been a regulatory affairs specialist for twelve years. She has seen inspections from both sides, having worked at investigator sites before joining a contract research organization. She understands that warning letters represent the most serious inspection outcomes, the cases where FDA determined that the violations were significant enough to warrant formal agency action.

But as she begins reading, she notices something that confirms what she has long suspected. The same deficiencies appear again and again. Missing consent forms. Incomplete delegation logs. Gaps in investigational product accountability. Version control failures. Monitoring reports that were never finalized. The specific sites and sponsors differ, but the patterns are remarkably consistent.

"These are not novel problems," she tells her colleague Marcus Okonkwo during their afternoon meeting. "These are the same problems, happening at different sites, for the same underlying reasons. If we can understand the root causes, we can prevent them."

This lesson is about those patterns. We will examine the most common TMF deficiencies cited in regulatory findings, understand why they occur, and recognize how small documentation gaps can compound into major inspection findings. My goal is not to frighten you with cautionary tales. It is to equip you with the knowledge to recognize vulnerabilities in your own documentation systems before an inspector does.